{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:08:40Z","timestamp":1791065320616,"version":"4.1.0"},"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T00:00:00Z","timestamp":1538092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0203672","type":"journal-article","created":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T17:40:31Z","timestamp":1538156431000},"page":"e0203672","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":85,"title":["Integrating the skin and blood transcriptomes and serum proteome in hidradenitis suppurativa reveals complement dysregulation and a plasma cell signature"],"prefix":"10.1371","volume":"13","author":[{"given":"Lauren K.","family":"Hoffman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis E.","family":"Tomalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niroshana","family":"Anandasabapathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Alavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayte","family":"Su\u00e1rez-Fari\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4256-478X","authenticated-orcid":true,"given":"Michelle A.","family":"Lowes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,9,28]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.12788\/j.sder.2017.017","article-title":"Pathophysiology of hidradenitis suppurativa","volume":"36","author":"LK Hoffman","year":"2017","journal-title":"Semin Cutan Med Surg"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"MA Lowes","year":"2014","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ni.3790","article-title":"A guiding map for inflammation","volume":"18","author":"MG Netea","year":"2017","journal-title":"Nat Immunol"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/bjd.14371","article-title":"Gene expression profiling of skin and blood in hidradenitis suppurativa","volume":"174","author":"JL Blok","year":"2016","journal-title":"Br J Dermatol"},{"key":"ref5","article-title":"Intrinsic defect in keratinocyte function leads to inflammation in Hidradenitis suppurativa","author":"C Hotz","year":"2016","journal-title":"J Invest Dermatol"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/bjd.14338","article-title":"Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum","volume":"174","author":"JL Blok","year":"2016","journal-title":"Br J Dermatol"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jaad.2017.03.016","article-title":"Gene expression of sphingolipid metabolism pathways is altered in hidradenitis suppurativa","volume":"77","author":"M Dany","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"ref8","article-title":"Identification of atorvastatin for moderate to severe hidradenitis through drug repositioning using public gene expression dataset","author":"KY Kuo","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/cea.12979","article-title":"Identification of unique proteomic signatures in allergic and non-allergic skin disease","volume":"47","author":"J Wang","year":"2017","journal-title":"Clin Exp Allergy"},{"issue":"18","key":"ref10","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1093\/bioinformatics\/bth449","article-title":"limmaGUI: a graphical user interface for linear modeling of microarray data","volume":"20","author":"JM Wettenhall","year":"2004","journal-title":"Bioinformatics"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"S Hanzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"AM Newman","year":"2015","journal-title":"Nat Methods"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"e44274","DOI":"10.1371\/journal.pone.0044274","article-title":"Meta-analysis derived (MAD) transcriptome of psoriasis defines the &quot;core&quot; pathogenesis of disease","volume":"7","author":"S Tian","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2017.06.016","article-title":"IFNgamma-Dependent Tissue-Immune Homeostasis Is Co-opted in the Tumor Microenvironment","volume":"170","author":"CJ Nirschl","year":"2017","journal-title":"Cell"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/jid.2010.165","article-title":"A subpopulation of CD163-positive macrophages is classically activated in psoriasis","volume":"130","author":"J Fuentes-Duculan","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"5","key":"ref16","first-page":"1092","article-title":"Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways","volume":"159","author":"KE Nograles","year":"2008","journal-title":"Br J Dermatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12920-015-0133-x","article-title":"Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways","volume":"8","author":"DA Ewald","year":"2015","journal-title":"BMC Med Genomics"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1365-2133.2011.10643.x","article-title":"Alterations in leucocyte subsets and histomorphology in normal-appearing perilesional skin and early and chronic hidradenitis suppurativa lesions","volume":"166","author":"HH van der Zee","year":"2012","journal-title":"Br J Dermatol"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/bjd.14214","article-title":"Keratinocytes and neutrophils are important sources of proinflammatory molecules in hidradenitis suppurativa","volume":"174","author":"AL Lima","year":"2016","journal-title":"Br J Dermatol"},{"key":"ref20","article-title":"Polyclonal hyperglobulinemia and elevated acute phase reactants in hidradenitis suppurativa","author":"LK Hoffman","year":"2017","journal-title":"Br J Dermatol"},{"key":"ref21","article-title":"Successful treatment of hidradenitis suppurativa with rituximab for a patient with idiopathic carpotarsal osteolysis and chronic active antibody-mediated rejection","author":"K Takahashi","year":"2017","journal-title":"J Dermatol"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.immuni.2016.08.003","article-title":"Complement-Mediated Regulation of Metabolism and Basic Cellular Processes","volume":"45","author":"C Hess","year":"2016","journal-title":"Immunity"},{"issue":"12","key":"ref23","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/ni.3858","article-title":"Novel mechanisms and functions of complement","volume":"18","author":"G Hajishengallis","year":"2017","journal-title":"Nat Immunol"},{"issue":"37","key":"ref24","doi-asserted-by":"crossref","first-page":"15061","DOI":"10.1073\/pnas.1307855110","article-title":"Complement modulates the cutaneous microbiome and inflammatory milieu","volume":"110","author":"C Chehoud","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref25","article-title":"Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis?","author":"T Kanni","year":"2018","journal-title":"Br J Dermatol"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/13543784.2018.1412430","article-title":"Investigational drugs in clinical trials for Hidradenitis Suppurativa","volume":"27","author":"P Theut Riis","year":"2018","journal-title":"Expert Opin Investig Drugs"},{"key":"ref27","article-title":"The microbiological landscape of anaerobic infections in Hidradenitis Suppurativa: a prospective metagenomic study","author":"H Guet-Revillet","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"9","key":"ref28","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1001\/jamadermatol.2017.0904","article-title":"The Follicular Skin Microbiome in Patients With Hidradenitis Suppurativa and Healthy Controls","volume":"153","author":"HC Ring","year":"2017","journal-title":"JAMA Dermatol"},{"issue":"1","key":"ref29","doi-asserted-by":"crossref","first-page":"1340085","DOI":"10.1080\/20002297.2017.1340085","article-title":"Porphyromonas gingivalis disturbs host-commensal homeostasis by changing complement function","volume":"9","author":"I Olsen","year":"2017","journal-title":"J Oral Microbiol"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2340\/00015555-0749","article-title":"Increased serum tumour necrosis factor-alpha in hidradenitis suppurativa patients: is there a basis for treatment with anti-tumour necrosis factor-alpha agents?","volume":"89","author":"L Matusiak","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"ref31","article-title":"Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents","author":"L Matusiak","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"ref32","doi-asserted-by":"crossref","first-page":"82","DOI":"10.5114\/ada.2017.65626","article-title":"Increased serum interleukin-6 levels in patients with hidradenitis suppurativa","volume":"34","author":"H Xu","year":"2017","journal-title":"Postepy Dermatol Alergol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2450401","DOI":"10.1155\/2017\/2450401","article-title":"The Clinical Significance of Increased Serum Proinflammatory Cytokines, C-Reactive Protein, and Erythrocyte Sedimentation Rate in Patients with Hidradenitis Suppurativa","volume":"2017","author":"D Jimenez-Gallo","year":"2017","journal-title":"Mediators Inflamm"},{"key":"ref34","article-title":"Interleukin-32 is highly expressed in lesions of hidradenitis suppurativa","author":"R Thomi","year":"2017","journal-title":"Br J Dermatol"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1016\/j.jid.2017.05.033","article-title":"Hidradenitis Suppurativa Is Characterized by Dysregulation of the Th17:Treg Cell Axis, Which Is Corrected by Anti-TNF Therapy","volume":"137","author":"B Moran","year":"2017","journal-title":"J Invest Dermatol"},{"issue":"23","key":"ref36","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1016\/j.febslet.2011.03.023","article-title":"Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases","volume":"585","author":"T Tanaka","year":"2011","journal-title":"FEBS Lett"},{"issue":"1","key":"ref37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1189\/jlb.4RU0416-175RR","article-title":"Interleukin 32: a novel player in the control of infectious diseases","volume":"101","author":"F Ribeiro-Dias","year":"2017","journal-title":"J Leukoc Biol"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4110\/in.2014.14.3.123","article-title":"Interleukin-32 in inflammatory autoimmune diseases","volume":"14","author":"S. Kim","year":"2014","journal-title":"Immune Netw"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0203672","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T03:55:08Z","timestamp":1540353308000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0203672"}},"subtitle":[],"editor":[{"given":"Valerio","family":"De Vita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,9,28]]},"references-count":38,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0203672","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,28]]}}}